Disorders of the Immune Response

Jun 5, 2024

Disorders of the Immune Response

Chapter 16 Overview

  • Focus on disorders of the immune response.
  • Discuss hypersensitivity and inappropriate activation of the immune response.
  • Damage can be caused by the immune response rather than the pathogen.

Hypersensitivity

  • Definition: Excessive or inappropriate activation of the immune response.
  • Key Concept: Inflammation and its five cardinal signs (redness, heat, pain, swelling, loss of function).

Type 1 Hypersensitivity (Allergic Reactions)

  • Common Associations: Allergies, systemic reactions (e.g., anaphylaxis), local reactions (e.g., hives, rhinitis, atopic dermatitis, bronchial asthma).
  • Mechanism:
    • T helper cells are primed against a specific antigen.
    • Activation of T helper cells releases inflammatory cytokines (Interleukin 4, 5).
    • B cells turn into plasma cells that secrete IgE antibodies.
    • IgE antibodies are picked up by mast cells.
    • Mast cells degranulate, releasing histamine and other inflammatory mediators (e.g., cytokines, prostaglandins).
  • Symptoms: Vasodilation, increased vascular permeability, smooth muscle spasm, mucosal edema, increased mucus secretion.
  • Example: Anaphylaxis leading to massive vasodilation, decreased blood pressure, and shock.

Antibody-Mediated Hypersensitivity

Type 2 Hypersensitivity

  • Associations: Autoantibodies bind to antigens on cell surfaces (e.g., red/white blood cells).
  • Mechanism:
    • Antibodies (IgG, IgM) recognize antigens, leading to phagocytosis and cell damage.
    • Involvement of the complement system.
    • Examples include autoimmune diseases like Graves' disease and Myasthenia Gravis.

Type 3 Hypersensitivity

  • Delayed Hypersensitivity: Antigen-antibody complexes deposit on vessel walls.
  • Associations: Autoimmune vasculitis, glomerulonephritis, serum sickness.
  • Mechanism: Complement activation, inflammation, and tissue damage.
  • Example: Kidney damage due to glomerulonephritis leading to renal failure.

Type 4 Hypersensitivity

  • Cell-Mediated: T-cells are hypersensitive and cause cell damage.
  • Delayed Hypersensitivity: Involvement of macrophages, cytotoxic T-cells, and T helper cells.
  • Associations: Tuberculin test, contact dermatitis, graft-versus-host disease.

Immunodeficiency

  • Definitions: Underactive immune response (B cells, T cells, or both).
  • Primary Immunodeficiency Examples:
    • Severe Combined Immunodeficiency (SCID)
    • Thymic Hypoplasia (DiGeorge Syndrome)
    • Wiskott-Aldrich Syndrome
  • Acquired Immunodeficiency Examples: Malnutrition, immunosuppressant drugs, radiation, HIV/AIDS.

HIV/AIDS

  • Transmission: Direct contact (blood, sexual contact, breast milk).
  • Infects: CD4+ cells (T helper cells, dendritic cells, neurons).
  • HIV Mechanism:
    • HIV is an RNA virus using reverse transcriptase to convert RNA to DNA.
    • Integrates into host genome, leading to lifelong infection.
    • High mutation rate complicates treatment.
  • Clinical Progression:
    • Primary phase: fever, systemic symptoms.
    • Latent phase: low viral count, gradual T helper cell decline.
    • AIDS: less than 200 T-helper cells/mL, increased risk of opportunistic infections and malignancies.
  • Treatment Targets: Reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, integrase inhibitors.

Autoimmune Diseases

  • Definition: Breakdown of self-tolerance, leading to immune system attacking self-antigens and body tissues.
  • Cause: Hyperactive immune system responding to self-antigens.
  • Examples and Mechanisms: Can span a wide variety of body tissues and functions.

Blood Transfusion and Rh Factor

  • Universal Donor: Type O blood (lack of A or B antigens).
  • Rh Factor: Rh incompatibility in pregnancy can lead to erythroblastosis fetalis; managed using Rhogam.

Organ Graft Rejection

  • Types: Hyperacute, acute, chronic.
  • Mechanism: Preformed antibodies, T cell response against graft antigens, and gradual blood vessel damage.

Graft-Versus-Host Disease (GVHD)

  • Cause: Donor T cells attack recipient’s body tissues.
  • Risk Factors: MHC compatibility, gender mismatch, high parity in women.
  • Management: Testing for MHC compatibility and monitoring symptoms.